The Pfizer delegation and representatives from Pingshan District pose for photo during the delegation’s recent visit in Pingshan. Photos from Pingshan Media Center

A delegation led by Kathy Fernando, senior vice president and global head of Pfizer Ignite within the Business Innovation Office at Pfizer, visited Pingshan District recently.

During the visit, Fernand and her team learned about the industrial innovation ecosystem, international cooperation environment, and future collaboration opportunities in Shenzhen and Pingshan. She expressed admiration for Shenzhen's favorable business landscape, noting the rapid growth of the biopharmaceutical industry in the Guangdong-Hong Kong-Macao Greater Bay Area, where numerous innovative companies have emerged.

Kathy Fernando and her team visit Pingshan District.

Fernando highlighted the Pfizer Ignite program, launched in China in 2023, which provides specialized services to clinical-stage and commercialization-stage biotech companies, including overseas clinical trials and regulatory approvals. She emphasized that Pfizer welcomes diverse forms of collaboration with Shenzhen’s biotech partners, such as business development transactions, equity investments, and mergers and acquisitions.

The meeting provided an opportunity for both parties to strengthen communication and explore potential collaborations in areas including pharmaceutical R&D and project investments. Fernando underscored the importance of leveraging Pfizer’s global expertise and resources to assist Shenzhen’s biotech firms in expanding onto the international stage, fostering mutual benefits and promoting innovation in the biopharmaceutical sector.

To facilitate connections between local innovative pharmaceutical companies and Pfizer, representatives from over 10 Shenzhen enterprises engaged in discussions with the delegation, exploring cooperative opportunities for the future.

The Pfizer delegation and representatives from over 10 Shenzhen enterprises engage in discussions.